Theranostic Probes for Targeting Tumor Microenvironment: An Overview

Area of Science:

• Oncology
• Biomedical Engineering
• Nanotechnology

Background:

• Tumors are not isolated but interact with their surrounding tumor microenvironment (TME).
• TME components, including extracellular matrix, vasculature, and immune cells, significantly influence tumor progression, invasion, and metastasis.
• Tumor heterogeneity, driven by TME dynamics, presents challenges in cancer diagnosis and treatment.

Purpose of the Study:

• To review the critical roles of various tumor microenvironment components in promoting tumor growth and metastasis.
• To examine the recent advancements in nanotheranostics targeting the TME for cancer therapy, diagnosis, and drug delivery.
• To discuss the limitations and future prospects of nanoparticle-based theranostics combined with advanced imaging modalities.

Main Methods:

• Literature review focusing on the interactions within the tumor microenvironment.
• Analysis of the role of TME factors such as vasculature, extracellular matrix, and stromal cells in tumor progression.
• Examination of nanotheranostic strategies and their integration with imaging techniques like MRI, PET, and SPECT.

Main Results:

• The tumor microenvironment actively supports tumor proliferation, invasion, and metastasis through complex interactions.
• Nanotheranostics show promise for targeted cancer therapy, diagnosis, and drug delivery by exploiting TME characteristics.
• Combination of nanotheranostics with imaging modalities offers potential for enhanced cancer management.

Conclusions:

• Understanding the tumor microenvironment is crucial for developing effective cancer therapies.
• Targeting the TME with nanotheranostics represents a promising strategy for personalized cancer treatment.
• Further research is needed to optimize nanotheranostic approaches and overcome current limitations for improved clinical outcomes.